Gene · 7913
Papers1,526
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 1,526
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| DEK::NUP214 acts as an XPO1-dependent transcriptional activator of essential leukemia genes. | Leukemia | 2025 | 40204893 | PubTator, text mining | PubMed |
| Eupalinolide B targets DEK and PANoptosis through E3 ubiquitin ligases RNF149 and RNF170 to negatively regulate asthma. | Phytomedicine | 2025 | 40120540 | PubTator, text mining | PubMed |
| Proto-oncogene DEK binds to pre-mRNAs and regulates the alternative splicing of Hippo signaling genes in HeLa cells. | Mol Genet Genomics | 2025 | 40075046 | PubTator, text mining | PubMed |
| Acupuncture inhibits epithelial mesenchymal transition in allergic asthma rats by activating the PI3K/AKT pathway through DEK activation. | Zhen Ci Yan Jiu | 2025 | 40059051 | PubTator, text mining | PubMed |
| Structural insights into how DEK nucleosome binding facilitates H3K27 trimethylation in chromatin. | Nat Struct Mol Biol | 2025 | 39984731 | PubTator, text mining | PubMed |
| Inhibition of DEK restores hematopoietic stem cell function in Fanconi anemia. | J Exp Med | 2025 | 39836085 | PubTator, text mining | PubMed |
| DEK::AFF2 Squamous Cell Carcinomas of the Sinonasal Region and Temporal Bone Diagnosed After Recurrences: A Report of Two Patients. | Int J Surg Pathol | 2025 | 39819065 | PubTator, text mining | PubMed |
| Chromatin accessibility: biological functions, molecular mechanisms and therapeutic application. | Signal Transduct Target Ther | 2024 | 39627201 | PubTator, text mining | PubMed |
| DEK regulates B-cell proliferative capacity and is associated with aggressive disease in low-grade B-cell lymphomas. | Blood Cancer J | 2024 | 39384745 | PubTator, text mining | PubMed |
Clinical features and long-term outcomes of pediatric patients with de novo acute myeloid leukemia in China with or without specific gene abnormalities: a cohort study of patients treated with BCH-AML 2005. | Hematology | 2024 | 39361146 | PubTator, text mining | PubMed |
| Lipid profiling of RON and DEK-dependent signaling in breast cancer guides discovery of gene networks predictive of poor outcomes. | Front Oncol | 2024 | 39351361 | PubTator, text mining | PubMed |
| The chromatin remodeler DEK promotes proliferation of mammary epithelium and is associated with H3K27me3 epigenetic modifications. | bioRxiv | 2024 | 39314335 | PubTator, text mining | PubMed |
| [High-risk acute myeloid leukemia with DEK-NUP214 rearrangement and eyelid infiltration: a case report]. | Zhonghua Xue Ye Xue Za Zhi | 2024 | 38964929 | PubTator, text mining | PubMed |
| [Analysis of therapeutic effects of allogeneic hematopoietic stem cell transplantation in 12 patients with DEK-NUP214 fusion gene positive acute myeloid leukemia]. | Zhonghua Xue Ye Xue Za Zhi | 2024 | 38951067 | PubTator, text mining | PubMed |
| Molecularly defined sinonasal malignancies: an overview with focus on the current WHO classification and recently described provisional entities. | Virchows Arch | 2024 | 38491228 | PubTator, text mining | PubMed |
| Re-evaluating a historic cohort of sinonasal and skull base mucoepidermoid carcinoma: an institutional experience. | Diagn Pathol | 2024 | 38429827 | PubTator, text mining | PubMed |
| The Potential of Aqueous Humor Sampling in Diagnosis, Prognosis, and Treatment of Retinoblastoma. | Invest Ophthalmol Vis Sci | 2024 | 38180770 | PubTator, text mining | PubMed |
| Single-cell transcriptomics enable the characterization of local extension in retinoblastoma. | Commun Biol | 2024 | 38172218 | PubTator, text mining | PubMed |
| Isolation and detection of DNA-protein crosslinks in mammalian cells. | Nucleic Acids Res | 2024 | 38084926 | PubTator, text mining | PubMed |
| Prevalence and interpretation of AFF immunostain of DEK::AFF2 fusion-associated papillary squamous cell carcinoma in a retrospective cohort of recurrent sinonasal papillomas. | Virchows Arch | 2024 | 38063896 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7913/papers?page=3